Here are 1-2 brief analogies to describe Strata Critical Medical (SRTA):

• The medical device equivalent of AbbVie (maker of Humira) for chronic skin conditions.
• Intuitive Surgical (ISRG) for light-based dermatological devices.

The public company "Strata Critical Medical" with the symbol SRTA does not appear to exist as described.

The symbol SRTA is currently associated with Starry Group Holdings, Inc., which provides fixed wireless broadband internet services, not critical medical products or services.

Upon researching "Strata Critical Medical" with the symbol "SRTA", I was unable to find a currently trading public company matching this exact description. Public company databases and financial records do not list an active entity by this name and symbol combination on major stock exchanges.

Therefore, I cannot identify its major customers or categorize them as requested, as the foundational company information could not be verified.

null

Melissa Tomkiel, Co-Chief Executive Officer and General Counsel

Ms. Tomkiel has served as Strata's Co-CEO since August 2025, concurrent with the company's renaming from Blade Air Mobility. She has also been the General Counsel since February 2015. Previously, she held the role of President from January 2021 to August 2025 and President, Fixed Wing from 2015 to 2020. Before joining Strata, Ms. Tomkiel was President of LIMA NY Corp., a commuter air carrier, from 2010 to 2015. From 2006 to 2010, she practiced as an attorney at Pryor Cashman.

William Heyburn, Co-Chief Executive Officer, Chief Financial Officer and Director

Mr. Heyburn has been Co-CEO of Strata since August 2025 and Chief Financial Officer since December 2020. He also served as Head of Corporate Development from May 2018 to August 2025. Prior to his tenure at Strata, Mr. Heyburn was Vice President at Redbird Capital Partners from 2015 to 2018, demonstrating a pattern of managing companies backed by private equity firms. He also held a position on the U.S. Credit Investment Team at Oak Hill Advisors, L.P. from 2013 to 2015, and was part of the investment banking group at Moelis and Company, focusing on restructuring transactions, from 2011 to 2013.

Amir Cohen, Chief Accounting Officer

Mr. Cohen has served as Strata's Chief Accounting Officer since May 2021. Before joining Strata (formerly Blade Air Mobility), he was the SVP of Finance for WPP's Wunderman Thompson network. Earlier in his career, Mr. Cohen was a Manager at PwC.

Matt Schneider, Vice President of Finance and Investor Relations, CFO of Strata's Keystone Perfusion subsidiary

Mr. Schneider holds the titles of Vice President of Finance and Investor Relations and also serves as the Chief Financial Officer of Strata's Keystone Perfusion subsidiary.

Scott M. Wunsch, Chief Executive Officer, Trinity Air Medical

Mr. Wunsch is the Chief Executive Officer of Trinity Air Medical.

1. Expansion of Organ Recovery Platform and Clinical Services: Strata Critical Medical recently acquired Keystone Perfusion, a strategic move aimed at creating an integrated organ recovery platform and diversifying into additional medical services. This acquisition is expected to accelerate the company's exposure to higher-growth clinical services. The company has been launching new clinical services and supporting innovative technologies to become an end-to-end organ recovery platform.

2. New Customer Acquisition and Market Share Gains: The company has demonstrated consistent growth through the acquisition of new customers and expansion of its market share. In Q3 2025, Strata reported a 29.0% year-over-year organic revenue growth (excluding the Keystone acquisition), driven by both new customer additions and increased adoption of services by existing customers.

3. Growth of Existing Customer Services and Offerings: Strata's revenue growth is also fueled by existing customers adopting new services offered by the company. The company's strategy includes expanding its overall service offerings to its current client base, further integrating its solutions within the healthcare industry.

4. Strategic Focus on Critical Medical Logistics: Following the divestiture of its passenger business and rebranding from Blade Air Mobility, Strata Critical Medical is now solely focused on the time-critical logistics and medical services provider to the U.S. healthcare industry. This sharpened focus on its core medical segment, which includes air and ground logistics, surgical organ recovery, organ placement, and perfusion solutions, is expected to drive concentrated growth and operational efficiencies.

Share Issuance

• Strata Critical Medical issued 3,434,609 shares valued at approximately $16.8 million as part of the consideration for the Keystone Perfusion Services acquisition in September 2025.

Outbound Investments

• In September 2025, Strata Critical Medical acquired Keystone Perfusion Services for approximately $126.8 million, consisting of $109.963 million in cash and 3,434,609 shares valued at $16.828 million.
• The company divested its Passenger business to Joby Aviation in August 2025 for consideration valued at up to $125 million, which included $70.163 million in net cash proceeds from monetized Joby shares.

Capital Expenditures

• Capital expenditures totaled $3.2 million in the third quarter of 2025, primarily allocated to aircraft maintenance.